RxDoctor Payments Data

Jennifer Neumayer, NP

Family · Boise, IDNPI 1639432131

Payments from drug & device makers

$2,597in general payments, 2019–2025

Across 131 payments — averaging $19.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$966
  • Regeneron Healthcare Solutions, Inc.$311
  • GSK$204
  • CSL Behring$180
  • Novartis$167
  • Biocryst US Sales Co., LLC$152
  • plus $616 from 15 others

What the payments were for

  • Food & beverage$2,597100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,597 in reported general payments places this provider in the 85th percentile of 809 family providers in Idaho.

See all family providers in Idaho

Medicare billing

Part B allowed, 2024
$145,327
Medicare patients
55
Services billed
4,788

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Spiriva RespimatTiotropium Bromide20$10,433
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,740
Breo ElliptaFluticasone/Vilanterol14$8,939
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$8,833
DuleraMometasone/Formoterol14$4,168
Epinephrine15$3,765
Fluticasone-SalmeterolFluticasone Propion/Salmeterol27$2,907
SymbicortBudesonide/Formoterol Fumarate12$2,894
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate16$1,731
Azelastine Hcl54$1,106
Wixela InhubFluticasone Propion/Salmeterol13$807
Montelukast Sodium104$727
Ipratropium Bromide18$563
Albuterol Sulfate HfaAlbuterol Sulfate22$415
Omeprazole16$46

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$204$18,67929 claims
AstraZenecaBreztri Aerosphere, Symbicort$966$11,72826 claims
Boehringer IngelheimSpiriva Respimat$31$10,43320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 809 family providers in Idaho.

Other family in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →